Clinical Topics & News
California picks generic drug company Civica to produce low-cost insulin
Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin.
Some, not all, ultraprocessed foods linked to type 2 diabetes
The increased risk applies only to certain types of ultraprocessed foods, say researchers, who call for their consumption to be limited.
High caffeine levels may lower body fat, type 2 diabetes risks
Previous short-term studies have linked caffeine intake with reductions in weight and fat mass.
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.
Causal link found between childhood obesity and adult-onset diabetes
Bigger children have increased risks for almost all subtypes of adult-onset diabetes, a Mendelian randomization study indicates.
Two FDA clearances add diabetes technology options
The FDA has cleared Abbott Freestyle Libre versions 2 and 3 for integration with automated insulin delivery systems and Bigfoot Biomedical’s...
Heart-healthy actions promote longer, disease-free life
Stronger measures of cardiovascular health were linked to longer life expectancy and fewer chronic conditions.
High CV risk factor burden in young adults a ‘smoldering’ crisis
Cardiovascular risk factors are “unacceptably” high and are increasing among young adults, prompting calls for aggressive preventive measures.
COORDINATEd effort boosts optimal therapy in patients with T2D and ASCVD